COMPASS31 self questionnaire clinical trials

Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran

This study looks at how new medicines, Patisiran or Vutrisiran, affect the hearts of people in the UK with a specific type of inherited amyloidosis (ATTRv) that also causes nerve problems. It aims to understand if these treatments help their hearts over two years.